 |
|
|
|
|
|
|
|
Large-Scale Production Expertise and Experienced in Global Distribution
Teikoku is exceptionally skilled at developing, formulating, and adapting products for large-scale manufacturing—and distributing them in over 40 countries.
Teikoku's hydrogel patch production facility, the largest of its kind in the world, has been qualified by the FDA, European regulatory authorities, and Japan. The facility sets the gold standard in the industry for quality and safety.
Responsive to Your Needs
While this facility can produce up to four billion patches annually, our knowledge of customers' often-changing needs provide for nimble operations and quick, effective responses to your needs.
With manufacturing facilities in Japan, China, and now the United States, our capabilities include:
Transdermal products:
» Hydrogel patches
» Anhydrous tapes
» Creams and
ointments
|
|
Oral dosage
forms:
» Unit-dose liquids
» Unit-dose jellies
» Herbal powders
|
|
Transmucosal products:
» Biodegradable
patches
» Multilayer patches
|
|
|
|
|
|
 |
Copyright © 2006 Teikoku Pharma USA, Inc. All Rights Reserved.
Teikoku Pharma USA, Teikoku, Teikoku Pharma, Teikoku Seiyaku Co., drug delivery systems, TDS, patches, unit-dose jellies, unit-dose liquids, creams and ointments, delivery products, pain management, cosmetic care, TDS technologies, patent protections, prescription, otcs, medical device market, applications, transdermal drug delivery technologies, Lidoderm, Endo Pharmaceuticals, post-herpetic neuralgia, TDS-based health and beauty products, face masks, anti-wrinkle patches, skin whiteners, and cuticle softe
|
|
